Ketamina, una ‘nueva frontera’ para entender las enfermedades mentales
En una clínica con vistas al lago Union, con paredes de musgo y cojines en el suelo, Bridget Carnahan atiende a pacientes de enfermedades mentales con vendas en los ojos,...
Home > Reviews
All Stories
FDA approves nasal spray to treat migraines, promising ‘efficacy on demand’
SEATTLE — Impel NeuroPharma, a Seattle-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration last week for its novel nasal spray that treats migraine headaches. The therapeutic,...